http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c1898987387afbf3246671f3fa84fd54
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Lothe Ragnhild A. Lothe |
| name | Ragnhild A Lothe Ragnhild A. Lothe |
| given-name | Ragnhild A. Ragnhild A |
| organization-name | 3Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway Department of Cancer Prevention Institute for Cancer Research The Norwegian Radium Hospital Oslo University Hospital Oslo Norway; Centre for Cancer Biomedicine University of Oslo Oslo Norway; Faculty of Medicine University of Oslo Oslo Norway Authors' Affiliations: 1Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital; Departments of 2Gastrointestinal Surgery and 3Oncology, Oslo University Hospital; and 4Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Authors' Affiliations: 1Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital; Departments of 2Gastrointestinal Surgery and 3Oncology, Oslo University Hospital; and 4Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway Centre for Cancer Biomedicine, University of Oslo Oslo Norway; Department of Cancer Prevention Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital Oslo Norway Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Institute for Biosciences, University of Oslo, Oslo, Norway; K.G. Jebsen Colorectal Cancer Research Center, Oslo University Hospital, Oslo, Norway 1Department of Molecular Oncology, Institute for Cancer Research, the Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; 2K.G. Jebsen Colorectal Cancer Research Centre, Clinic for Cancer Medicine, Oslo University Hospital, Oslo, Norway.; 3Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway. Department of Cancer Prevention, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway; Department of Molecular Biosciences, University of Oslo, Oslo, Norway Department of Cancer Prevention (S.M.K., S.A., R.I.S., R.A.L.), Institute for Cancer Research, Norwegian Radium Hospital,Oslo University Hospital, N-0310 Oslo, Norway; Cancer Stem Cell Innovation Center (S.A., R.I.S., R.A.L.), Oslo University Hospital, N-0310 Oslo, Norway;; Centre for Cancer Biomedicine (S.M.K., S.A., R.I.S., R.A.L.), Faculty of Medicine, University of Oslo, N-0310 Oslo, Norway; 1Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; 2K.G.Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway.; 7Institute for Clinical Medicine, University of Oslo, Oslo, Norway. Authors' Affiliations: 1Cancer Epigenetics Group, and 2Department of Genetics, Portuguese Oncology Institute – Porto, Porto, Portugal; 3Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; 4Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway; 5Department of Pathology, Portuguese Oncology Institute – Porto, Porto, Portugal; 6Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal; 7Department of Urology, Portuguese Oncology Institute – Porto, Porto, Portugal; 8Faculty of Medicine, University of Oslo, Norway; and 9Cancer Genetics Group, Research Center of the Portuguese Oncology Institute – Porto, Porto, Portugal; Authors' Affiliations: 1Cancer Epigenetics Group, and 2Department of Genetics, Portuguese Oncology Institute – Porto, Porto, Portugal; 3Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; 4Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway; 5Department of Pathology, Portuguese Oncology Institute – Porto, Porto, Portugal; 6Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal; 7Department of Urology, Portuguese Oncology Institute – Porto, Porto, Portugal; 8Faculty of Medicine, University of Oslo, Norway; and 9Cancer Genetics Group, Research Center of the Portuguese Oncology Institute – Porto, Porto, Portugal; Authors' Affiliations: 1Cancer Epigenetics Group, and 2Department of Genetics, Portuguese Oncology Institute – Porto, Porto, Portugal; 3Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; 4Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway; 5Department of Pathology, Portuguese Oncology Institute – Porto, Porto, Portugal; 6Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal; 7Department of Urology, Portuguese Oncology Institute – Porto, Porto, Portugal; 8Faculty of Medicine, University of Oslo, Norway; and 9Cancer Genetics Group, Research Center of the Portuguese Oncology Institute – Porto, Porto, Portugal Department of Molecular Oncology,Institute for Cancer Research,Oslo University Hospital–The Norwegian Radium Hospital,Oslo,Norway; Centre for Cancer Biomedicine, Faculty of Medicine,University of Oslo,Oslo,Norway 1Department of Molecular Oncology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; 2Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, 0310 Oslo, Norway; Centre for Cancer Biomedicine, University of Oslo, 0310 Oslo, Norway Department of Molecular Oncology Institute for Cancer Research, Oslo University Hospital Oslo Norway; Faculty of Medicine Institute of Clinical Medicine, University of Oslo Oslo Norway; Division for Cancer Medicine K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital Oslo Norway; Department of Biosciences, The Faculty of Mathematics and Natural Sciences University of Oslo Oslo Norway Department of Cancer Prevention Institute for Cancer Research, the Norwegian Radium Hospital, Oslo University Hospital Oslo Norway; Centre for Cancer Biomedicine Faculty of Medicine, University of Oslo Oslo Norway; Department of Biosciences University of Oslo Oslo Norway; Cancer Stem Cell Innovation Center (CAST) Oslo University Hospital Oslo Norway Department of Molecular Oncology, Institute for Cancer Research Oslo University Hospital Oslo Norway; K.G.Jebsen Colorectal Cancer Research Centre Oslo University Hospital Oslo Norway; Institute for Clinical Medicine University of Oslo Oslo Norway Department of Molecular Oncology Institute for Cancer Research, Oslo University Hospital ‐ Norwegian Radium Hospital Oslo Norway; K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital Oslo Norway; Centre for Cancer Biomedicine, Faculty of Medicine University of Oslo Oslo Norway; Department of Biosciences, Faculty of Mathematics and Natural Sciences University of Oslo Oslo Norway Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Institute for Biosciences, University of Oslo, Oslo, Norway; K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway 1Department of Genetics, Institute for Cancer Research and Departments of Department of Molecular Oncology, Institute for Cancer Research Oslo University Hospital–Radiumhospitalet Oslo Norway; Institute of Clinical Medicine, Faculty of Medicine University of Oslo Oslo Norway Department of Cancer Prevention, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Centre, Oslo, Norway; Department of Molecular Biosciences, University of Oslo, Oslo, Norway Centre for Cancer Biomedicine, Faculty of Medicine, Oslo University Hospital Oslo Norway; Department of Cancer Prevention, Institute for Cancer Research, Oslo University Hospital Norway From the Department of Cancer Prevention, Institute for Cancer Research; Division of Cancer Medicine and Radiotherapy; and Division of Pathology, Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital; Center for Cancer Biomedicine and Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Genetics, Portuguese Oncology Institute; Biomedical Sciences Institute, University of Porto, Porto, Portugal. Department of Medical Genetics, University Hospital of Groningen, the... Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; K.G.Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway 1Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital-Norwegian Radium Hospital, Oslo, Norway.; 2Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway. Authors' Affiliations: 1Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital; and 2Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Authors' Affiliations: 1Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital; and 2Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway Department of Molecular Oncology Institute for Cancer Research, Oslo University Hospital Oslo Norway; K.G. Jebsen Colorectal Cancer Research Center Oslo University Hospital Oslo Norway; Institute of Clinical Medicine, Faculty of Medicine University of Oslo Oslo Norway Authors' Affiliations: 1Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, 2Department of Gastrointestinal Surgery, Aker University Hospital, Oslo University Hospital; 3Centre for Cancer Biomedicine, Faculty of Medicine, 4Department of Informatics, University of Oslo; 5Department of Forensic Pathology And Clinical Forensic Medicine, Division for Forensic Medicine, The Norwegian Institute of Public Health, Oslo; and 6Akershus University Hospital, University of Oslo, Research Centre, Lørenskog, Norway; Authors' Affiliations: 1Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, 2Department of Gastrointestinal Surgery, Aker University Hospital, Oslo University Hospital; 3Centre for Cancer Biomedicine, Faculty of Medicine, 4Department of Informatics, University of Oslo; 5Department of Forensic Pathology And Clinical Forensic Medicine, Division for Forensic Medicine, The Norwegian Institute of Public Health, Oslo; and 6Akershus University Hospital, University of Oslo, Research Centre, Lørenskog, Norway From the Department of Clinical Cancer Research; Department of Cancer Prevention, Institute for Cancer Research; Department of Biostatistics, Rikshospitalet-Radiumhospitalet Medical Center; and the Faculty of Medicine and Department of Molecular Biosciences, University of Oslo, Oslo, Norway 7Department of Genetics, Institute for Cancer Research, Norwegian Radium Hospital; and; 8Department of Molecular Biosciences, University of Oslo, Oslo, Norway From the Departments of Genetics and Pathology, Institute for Cancer Research, and the Department of Oncology, the Norwegian Radium Hospital and University of Oslo, Oslo, Norway; the Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere; Biomedicum Biochip Center, Biomedicum Helsinki, Helsinki; and VTT Technical Research Centre of Finland and University of Turku, Turku, Finland; Cancer Genetics Branch, National Human Genome Research... Department of Molecular Oncology Institute for Cancer Research the Norwegian Radium Hospital Oslo University Hospital Norway; Centre for Cancer Biomedicine University of Oslo Norway K G Jebsen Colorectal Cancer Research Centre, Oslo, Norway; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. Department of Cancer Prevention Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital Oslo Norway; Faculty of Medicine Centre for Cancer Biomedicine, University of Oslo Oslo Norway Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway; Department of Molecular Oncology, Oslo University Hospital, Oslo, Norway 1Department for Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; 2K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway.; 3Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; 4Department of Molecular Biosciences, University of Oslo, Oslo, Norway. Department of Cancer Prevention, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Cancer Stem Cell Innovation Centre, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. Authors' Affiliations: Divisions of 1Stem Cell Biology and Developmental Genetics and 2Developmental Neurobiology, MRC National Institute for Medical Research, Mill Hill, London, United Kingdom; 3Tumor Suppression Group, 4Comparative Pathology Unit, Spanish National Cancer Research Centre (CNIO), Madrid; 5Neuroscience Division, Biodonostia Institute, Paseo Dr. Begiristain s/n; and 6Department of Gastroeneterology, Hospital Donostia - Instituto Biodonostia, University of Country Basque, Centro de Investigacion Biomedica en Red en Enfermedades Hepaticas y Digestivas (CIBERehd), San Sebastian, Gipuzkoa, Spain; 7Department of Cancer Prevention, Institute for Cancer Research, Oslo University Hospital–The Norwegian Radium Hospital, and Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway; 8Department of Biochemistry, The University of Hong Kong, Hong Kong; and 9Laboratoire de Génétique du Dévelopement Normal et Pathologique, Centre de Biochimie, Université de Nice-Sophia Antipolis, From the Department of Genetics, Institute for Cancer Research, and the Department of Surgery, The Norwegian Radium Hospital; Institute of Forensic Medicine, The National Hospital; and Section of Medical Statistics, University of Oslo, Oslo, Norway. Department of Molecular Oncology Institute for Cancer Research the Norwegian Radium Hospital Oslo University Hospital Norway; K.G. Jebsen Colorectal Cancer Research Centre Clinic for Cancer Medicine Oslo University Hospital Norway; Institute for Clinical Medicine Faculty of Medicine University of Oslo Norway Department of Molecular Oncology Institute for Cancer Research Oslo University Hospital – The Norwegian Radium Hospital Oslo Norway; Institute of Clinical Medicine Faculty of Medicine University of Oslo Oslo Norway Norwegian Cancer Genomics Consortium, Oslo, Norway;; Institute of Clinical Medicine, Faculty of Medicine,; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital-Norwegian Radium Hospital, Oslo, Norway; KG Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway; Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Nydalen, Oslo, Norway; Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway Department of Molecular Oncology, Institute for Cancer research, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway |
Incoming Links
Total number of triples: 257.